Press Releases

OstéoQC Closes Seed Financing Round07-Nov-2014

OsteoQC Closes Seed Financing Round Montreal (Nov11, 2014) ..

OSTEOGENEX ANNOUNCES ISSUANCE OF A U.S. PATENT COVERING ANTI-SCLEROSTIN BISPHOSPHONATE COMBINATION T01-Jun-2012

OsteoGeneX, a Kansas City, Kansas-based pharmaceutical company, is focused on commercializing or..

OSTEOGENEX HONORED WITH TOP PRESENTATION AT VENTURE SUMMIT ON WALL STREET29-Mar-2012

OsteoGeneX, a Kansas City, Kansas-based pharmaceutical company, focused on commercializing orall..

OSTEOGENEX NAMED ONE OF TOP 50 NATIONAL INNOVATORS AT THE 2012 LIFE SCIENCES & HEALTH12-Mar-2012

Osteogenex Named One of Top 50 National Innovators At The 2012 Life Sciences & Health Ventur..

OsteoGeneX to Spin Off Commercialization Entity04-Oct-2011

OsteoGeneX to Spin Off Commercialization Entity New Chief Commercial Officer to Drive Bone Thera..

OsteoGenex raises $1.4M more for bone-growth products research01-Jun-2011

OSTEOGENEX RAISES ADDITIONAL $1.4M IN CAPITAL AND ADDS MEMBER TO SCIENTIFIC ADVISORY BOARD ‐ COR..